Title : A novel somatic BRCA2 point mutation in a metastatic pancreatic cancer patient: a case report.

Pub. Date : 2021 Jan 6

PMID : 33407459






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Recent studies demonstrated a significant progression-free survival (PFS) benefit from maintenance olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor administered to patients with germline BRCA mutations and metastatic pancreatic cancer. olaparib BRCA1 DNA repair associated Homo sapiens